The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 4 , Pages 807-812 , April 2009

Gender difference in survival of resected non–small cell lung cancer: Histology-related phenomenon?

  • Jee Won Chang, MD

      Affiliations

    • Cheju National University Hospital, School of Medicine, Cheju National University, Jeju, South Korea
    • ,
  • Hisao Asamura, MD

      Affiliations

    • Division of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan
    • Corresponding Author InformationAddress for reprints: Hisao Asamura, MD, Division of Thoracic Surgery, National Cancer Center Hospital 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104-0045, Japan.
    • ,
  • Riken Kawachi, MD

      Affiliations

    • Division of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan
    • ,
  • Shun-ichi Watanabe, MD

      Affiliations

    • Division of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan

Received 23 March 2008 ,Revised 25 August 2008 ,Accepted 12 September 2008.

References 

  1. Ferguson MK, Wang J, Hoffman PC, Haraf DJ, Olak J, Masters GA, et al. Sex-associated differences in survival of patients undergoing resection for lung cancer. Ann Thorac Surg. 2000;69:245–250
  2. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20,561 cases. Ann Oncol. 2002;13:1087–1093
  3. Cerfolio RJ, Bryant AS, Scott E, Sharma M, Robert F, Spencer SA, et al. Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men. Chest. 2006;130:1796–1802
  4. Asamura H, Goya T, Koshiishi Y, Sohara Y, Eguchi K, Mori M, et al. A Japanese lung cancer registry study prognosis of 13,010 resected lung cancers. J Thorac Oncol. 2008;3:46–53
  5. Goya T, Asamura H, Yoshimura H, Kato H, Shimokata K, Tsuchiya R, et al. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer. 2005;50:227–234
  6. Hanagiri T, Sugio K, Uramoto H, So T, Ichiki Y, Sugaya M, et al. Gender difference as a prognostic factor in patients undergoing resection of non-small cell lung cancer. Surg Today. 2007;37:546–551
  7. Foegle J, Hedelin G, Lebitasy M, Purohit A, Velten M, Quoix E. Specific features of non-small cell lung cancer in women: a retrospective study of 1738 cases diagnosed in Bas-Rhin between 1982 and 1997. J Thorac Oncol. 2007;2:466–474
  8. Moro D, Nagy-Mignotte H, Bolla M, Colonna M, Brichon P, Brambilla C, et al. Evaluation of survival and prognostic factors in 2,000 broncho-pulmonary cancers registered during 10 years in an oncology department. Bull Cancer. 1997;84:155–161
  9. Wittekind CH, Henson DE, Hutter RVP, Sobin LH. In: International Union Against Cancer TNM Classification of Malignant Tumors. 6th ed. New York: Wiley-Liss; 1997;
  10. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E, Sobin LH. In:  Brambilla E,  Travis WD editor. Histological Typing of Lung and Pleural Tumors. 3rd ed.. Berlin: Springer-Verlag; 1999;p. 155
  11. Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S, et al. Small adenocarcinoma of the lung. Cancer. 1995;75:2844–2852
  12. Kirklin JW, Barratt-Boyes BG. Generating knowledge from information, data, and analyses. In:  Kirklin JW,  Barratt-Boyes BG editor. Cardiac Surgery. New York: Churchill Livingstone; 2003;p. 254–350
  13. Alexiou C, Onyeaka CVP, Beggs D, Akar R, Beggs L, Salama FD, et al. Do women live longer following lung resection for carcinoma?. Eur J Cardiothorac Surg. 2002;21:319–325
  14. Mountain CF, Lukeman JM, Hammar SP, Chamberlain DW, Coulser DL, Victor TA, et al. Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trial population. J Surg Oncol. 1987;35:147–156
  15. Kadri MA, Dussek JE. Survival and prognosis following resection of primary non-small cell bronchogenic carcinoma. Eur J Cardiothorac Surg. 1991;5:132–136
  16. Ichinose Y, Yano T, Asoh H, Yokoyama H, Yoshino I, Katsuda Y. Prognostic factors obtained by a pathologic examination in completely resected non-small cell lung cancer. J Thorac Cardiovasc Surg. 1995;110:601–605
  17. Donati V, Fontanini G, Dell'Omodarme M, Prati MC, Nuti S, Lucchi M, et al. WWOX expression in different histologic types and subtypes of non-small cell lung cancer. Clin Cancer Res. 2007;13:884–891
  18. Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, et al. Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol. 2008;32:810–827
  19. Fasco MJ, Hurteau GJ, Spivack SD. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol. 2002;188:125–140
  20. Montgrain PR, Quintana R, Rascon Y, Burton DW, Deftos LJ, Casillas A, et al. Parathyroid hormone-related protein varies with sex and androgen status in non-small cell lung cancer. Cancer. 2007;110:1313–1320
  21. Zheng S, El-Naggar AK, Kim ES, Kurie JM, Lozano G. A genetic mouse model for metastatic lung cancer with gender differences in survival. Oncogene. 2007;26:6896–6904
  22. Albain KS, Crowley JJ, LeBlanc M, Livingston RB. Survival determinants in extensive-stage non-small cell lung cancer: The Southwest Oncology Group experience. J Clin Oncol. 1991;9:1618–1626
  23. Ko Y, Lee C, Chen M, Huang C, Chang W, Lin H, et al. Risk factors for primary lung cancer among non-smoking women in Taiwan. Int J Epidemiol. 1997;26:24–31
  24. Wu AH, Fontham ETH, Reynolds P, Greenberg RS, Buffler P, Liff J, et al. Family history of cancer and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol. 1996;143:535–542
  25. Kiyohara C, Wakai K, Mikami H, Sido K, Ando M, Ohno Y. Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of environmental tobacco smoke and lung cancer: a case-control study in Japanese nonsmoking women. Int J Cancer. 2003;107:139–144
  26. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, et al. Activating mutations in epidermal growth factor receptor underlying responsiveness of non-small cell lung cancer to gefitinib. N Engl J Med. 2004;350:2129–2139

PII: S0022-5223(08)01574-2

doi: 10.1016/j.jtcvs.2008.09.026

The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 4 , Pages 807-812 , April 2009

Article Tools

* Image Usage & Resolution